دورية أكاديمية

PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma

التفاصيل البيبلوغرافية
العنوان: PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma
المؤلفون: Smeester, Branden A., Slipek, Nicholas J., Pomeroy, Emily J., Laoharawee, Kanut, Osum, Sara H., Larsson, Alex T., Williams, Kyle B., Stratton, Natalie, Yamamoto, Kenta, Peterson, Joseph J., Rathe, Susan K., Mills, Lauren J., Hudson, Wendy A., Crosby, Margaret R., Wang, Minjing, Rahrmann, Eric P., Moriarity, Branden S., Largaespada, David A.
المساهمون: Genentech, Inc., NIH, University of Minnesota, Boston Children's Hospital, Zach Sobiech OSA Fund Award, Randy Shaver Cancer Research and Community Fund, Aflac-AACR, Children's Cancer Research Fund, American Cancer Society
المصدر: Bone ; volume 136, page 115353 ; ISSN 8756-3282
بيانات النشر: Elsevier BV
سنة النشر: 2020
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Histology, Physiology, Endocrinology, Diabetes and Metabolism
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.bone.2020.115353
الإتاحة: https://doi.org/10.1016/j.bone.2020.115353Test
https://api.elsevier.com/content/article/PII:S8756328220301332?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S8756328220301332?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.BFE96C23
قاعدة البيانات: BASE